Suppr超能文献

利用动态 4D 血流模拟预测不同剂量率和分割质子治疗患者的放射性淋巴细胞减少症严重程度。

Predicting Severity of Radiation Induced Lymphopenia in Individual Proton Therapy Patients for Varying Dose Rate and Fractionation Using Dynamic 4-Dimensional Blood Flow Simulations.

机构信息

Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

Radiation Epidemiology Branch, National Cancer Institute, Rockville, Maryland.

出版信息

Int J Radiat Oncol Biol Phys. 2023 Aug 1;116(5):1226-1233. doi: 10.1016/j.ijrobp.2023.01.054. Epub 2023 Feb 4.

Abstract

PURPOSE

Radiation-induced lymphopenia has gained attention recently as the result of its correlation with survival in a range of indications, particularly when combining radiation therapy (RT) with immunotherapy. The purpose of this study is to use a dynamic blood circulation model combined with observed lymphocyte depletion in patients to derive the in vivo radiosensitivity of circulating lymphocytes and study the effect of RT delivery parameters.

METHODS AND MATERIALS

We assembled a cohort of 17 patients with hepatocellular carcinoma treated with proton RT alone in 15 fractions (fx) using conventional dose rates (beam-on time [BOT], 120 seconds) for whom weekly absolute lymphocyte counts (ALCs) during RT and follow-up were available. We used HEDOS, a time-dependent, whole-body, blood flow computational framework, in combination with explicit liver blood flow modeling, to calculate the dose volume histograms for circulating lymphocytes for changing BOTs (1 second-300 seconds) and fractionations (5 fx, 15 fx). From this, we used the linear cell survival model and an exponential model to determine patient-specific lymphocyte radiation sensitivity, α, and recovery, σ, respectively.

RESULTS

The in vivo-derived patient-specific α had a median of 0.65 Gy (range, 0.30-1.38). Decreasing BOT to 1 second led to an increased average end-of-treatment ALC of 27.5%, increasing to 60.3% when combined with the 5-fx regimen. Decreasing to 5 fx at the conventional dose rate led to an increase of 17.0% on average. The benefit of both increasing dose rate and reducing the number of fractions was patient specificࣧpatients with highly sensitive lymphocytes benefited most from decreasing BOT, whereas patients with slow lymphocyte recovery benefited most from the shorter fractionation regimen.

CONCLUSIONS

We observed that increasing dose rate at the same fractionation reduced ALC depletion more significantly than reducing the number of fractions. High-dose-rates led to an increased sparing of lymphocytes when shortening the fractionation regimen, particularly for patients with radiosensitive lymphocytes at elevated risk.

摘要

目的

由于辐射诱导性淋巴细胞减少与多种适应症的生存率相关,尤其是当放疗(RT)与免疫治疗联合应用时,该现象引起了人们的关注。本研究旨在使用结合患者淋巴细胞耗竭情况的动态血液循环模型,推导循环淋巴细胞的体内放射敏感性,并研究 RT 传递参数的影响。

方法和材料

我们收集了 17 例单独接受质子 RT 治疗的肝细胞癌患者的队列资料,这些患者在 15 个分次中接受常规剂量率(照射时间[BOT],120 秒)治疗,在 RT 期间和随访期间每周都有绝对淋巴细胞计数(ALC)。我们使用 HEDOS,一种时间依赖性的、全身的、血流计算框架,结合明确的肝脏血流建模,来计算 BOT(1 秒至 300 秒)和分次(5 次、15 次)变化时循环淋巴细胞的剂量体积直方图。由此,我们使用线性细胞存活模型和指数模型分别确定患者特异性淋巴细胞放射敏感性α和恢复性σ。

结果

体内衍生的患者特异性α中位数为 0.65 Gy(范围,0.30-1.38)。将 BOT 降至 1 秒可使治疗结束时的平均 ALC 增加 27.5%,当与 5 次分次方案联合应用时,可增加至 60.3%。当采用常规剂量率降低至 5 次分次时,平均增加 17.0%。两种增加剂量率和减少分次数的方法均具有患者特异性:具有高敏感性淋巴细胞的患者从降低 BOT 中获益最大,而淋巴细胞恢复较慢的患者从较短的分次方案中获益最大。

结论

我们观察到,在相同的分次方案中增加剂量率比减少分次数更能显著减少 ALC 的耗竭。高剂量率在缩短分次方案时可增加淋巴细胞的保留,特别是对于风险较高的、具有放射敏感性淋巴细胞的患者。

相似文献

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验